您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报(医学版) ›› 2016, Vol. 54 ›› Issue (7): 69-74.doi: 10.6040/j.issn.1671-7554.0.2015.1146

• • 上一篇    下一篇

IRX5 mRNA在结直肠癌诊断及预后中的价值

刘童,张欣,王传新   

  1. 山东大学齐鲁医院检验医学中心, 山东 济南 250012
  • 收稿日期:2015-11-23 出版日期:2016-07-10 发布日期:2016-07-10
  • 通讯作者: 王传新. E-mail:cxwang@sdu.edu.cn E-mail:cxwang@sdu.edu.cn
  • 基金资助:
    国家自然科学基金(81301506,81472025);山东省科技发展基金(2014GSF118016)

Significance of IRX5 mRNA in the diagnosis and prognosis of colorectal cancer

LIU Tong, ZHANG Xin, WANG Chuanxin   

  1. Department of Clinical Laboratory, Qilu Hospital of Shandong University, Jinan 250012, Shandong, China
  • Received:2015-11-23 Online:2016-07-10 Published:2016-07-10

摘要: 目的 探讨易洛魁家族同源盒基因(IRX5)mRNA在结直肠癌组织中的表达与临床病理及预后的关系。 方法 收集17例炎症性肠病、48例增生性息肉、54例腺瘤、142例结直肠癌及癌旁正常组织手术切除标本,提取组织标本的总RNA,用实时定量PCR(RT-qPCR)方法测定IRX5 mRNA的表达水平,结合临床资料,对IRX5 mRNA的差异表达与结直肠癌患者临床病理信息和预后的相关性进行分析。 结果 在结直肠癌组织中IRX5 mRNA表达量明显高于其他各组。IRX5 mRNA的表达量与肿瘤大小、淋巴结转移和远处转移密切相关(P<0.05)。此外,IRX5 mRNA高表达组的无病生存率(DFS)和总生存率(OS)明显低于低表达组(P<0.001),并且高表达IRX5 mRNA为结直肠癌预后的独立危险因素(P=0.020, HR=1.863; 95%CI=1.101~3.152)。 结论 IRX5 mRNA在结直肠癌组织中表达升高,并且其表达量与肿瘤的恶性程度及预后相关,提示IRX5 mRNA可作为结直肠癌诊断及预后的标志物。

关键词: mRNA, 结直肠肿瘤, 预后, 实时定量PCR, 易洛魁族同源盒基因

Abstract: Objective To investigate the expression and clinical significance of iroquois homeobox(IRX5)mRNA in colorectal cancer(CRC). Methods Expressions of IRX5 mRNA were analyzed in 17 cases of inflammatory bowel diseases, 48 cases of hyperplastic polyp, 54 cases of colorectal adenoma, 142 CRC cases and 142 paired adjacent non-tumorous tissues by quantitative real-time polymerase chain reaction(RT-qPCR). The correlation between IRX5 mRNA expression and prognosis was analyzed. Results IRX5 mRNA expression was significantly elevated in the CRC group when compared with other groups(all P<0.001). In CRC, up-regulation of IRX5 mRNA expression was significantly correlated with tumor size, lymph node metastasis, and distant metastasis(all P<0.05). CRC patients with high IRX5 mRNA expression had poorer disease-free survival(DFS)and overall survival(OS)than those with low IRX5 mRNA expression(log-rank test, P<0.001). Further multivariable Cox regression analysis suggested that increased expression of IRX5 mRNA was an independent prognostic indicator for CRC(P=0.020, HR=1.863, 95%CI=1.101-3.152). Conclusion IRX5 mRNA expression is elevated in CRC, and associated with malignancy and prognosis of CRC, indicating that it may serve as a useful diagnostic and prognostic predictor.

Key words: Iroquois homeobox 5, Colorectal neoplasms, mRNA, RT-qPCR, Prognosis

中图分类号: 

  • R574
[1] 陈琼, 刘志才, 程兰平, 等. 2003~2007年中国结直肠癌发病与死亡分析[J]. 中国肿瘤, 2012, 21(3): 179-182. CHEN Qiong, LIU Zhicai, CHENG Lanping, et al. An analysis of incidence and mortality of colorectal cancer in China, 2003-2007[J]. China Cancer, 2012, 21(3): 179-182.
[2] Edwards BK, Noone AM, Mariotto AB, et al. Annual report to the nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer[J]. Cancer, 2014, 120(9): 1290-1314.
[3] Cheng CW, Chow RL, Lebel M, et al. The iroquois homeobox gene, Irx5, is required for retinal cone bipolar cell development[J]. Dev Biol, 2005, 287(1): 48-60.
[4] Bonnard C, Strobl AC, Shboul M, et al. Mutations in IRX5 impair craniofacial development and germ cell migration via SDF1[J]. Nat Genet, 2012, 44(6): 709-713.
[5] 杨惠洁, 余爽, 王静, 等. IRX1基因在肝癌中的表达及其临床意义[J]. 中国生物制品学杂志, 2012, 25(10): 1354-1357. YANG Huijie, YU Shuang, WANG Jing, et al. Expression and clinical significance of iroquois homebox gene IRX1 in human hepatocellular carcinoma cells[J]. Chin J Biologicals, 2012, 25(10): 1354-1357.
[6] 潘玉申, 于颖彦, 计骏, 等. 胃癌中IRX1的表达与启动子区甲基化的相关性[J]. 上海交通大学学报(医学版), 2007, 27(5): 524-527. PAN Yushen, YU Yingyan, JI Jun, et al. Correlation between expression of IRX1 gene and promoter sitem ethylation status in gastric cancer[J]. Journal of Shanghai Jiaotong University(Medical Science), 2007, 27(5): 524-527.
[7] Bosse A, Stoykova A, Nieselt-Struwe K, et al. Identification of a novel mouse iroquois homeobox gene, Irx5, and chromosomal localisation of all members of the mouse Iroquois gene family[J]. Dev Dyn, 2000, 218(1): 160-174.
[8] Schmutz J, Martin J, Terry A, et al. The DNA sequence and comparative analysis of human chromosome 5[J]. Nature, 2004, 431(7006): 268-274.
[9] Martin J, Han C, Gordon LA, et al. The sequence and analysis of duplication-rich human chromosome 16[J]. Nature, 2004, 432(7020): 988-994.
[10] Bruneau BG. Irx5: a transcription factor that regulates the cardiac repolarization gradient[J]. Med Sci(Paris), 2006, 22(3): 231-232.
[11] Myrthue A, Rademacher BL, Pittsenbarger J, et al. The iroquois homeobox gene 5 is regulated by 1,25-dihydroxyvitamin D3 in human prostate cancer and regulates apoptosis and the cell cycle in LNCaP prostate cancer cells[J]. Clin Cancer Res, 2008, 14(11): 3562-3570.
[12] Gartel AL, Tyner AL. Transcriptional regulation of the p21(WAF1/CIP1)gene[J]. Exp Cell Res, 1999, 246(2): 280-289.
[13] Gartel AL, Tyner AL. The role of the cyclin-dependent kinase inhibitor p21 in apoptosis[J]. Mol Cancer Ther, 2002, 1(8): 639-649.
[14] 郝艳萍, 胡顺明, 张世栋, 等. 干细胞标记物LGR5在结直肠癌发生发展中的表达及意义[J]. 山东大学学报(医学版), 2009, 47(8): 85-89. HAO Yanping, HU Shunming, ZHANG Shidong, et al. Expression and significance of stem cell marker LGR5 proteins in the development and progression of human colorectal carcinoma[J]. Journal of Shandong University(Health Sciences), 2009, 47(8): 85-89.
[15] Loomans HA, Andl CD. Intertwining of activin a and TGFbeta signaling: dual roles in cancer progression and cancer cell invasion[J]. Cancers, 2014, 7(1): 70-91.
[16] Martorell O, Barriga FM, Merlos-Suarez A, et al. Iro/IRX transcription factors negatively regulate Dpp/TGF-beta pathway activity during intestinal tumorigenesis[J]. EMBO Rep, 2014, 15(11): 1210-1218.
[1] 李梓绮,魏闫若雪,刘晓晗,刘春铖,赵然,刘玉昆. 长链非编码RNA HEATR3反义RNA 1参与结直肠癌发生发展的功能及其临床意义[J]. 山东大学学报 (医学版), 2025, 63(9): 108-115.
[2] 刘保国,宋翔,赵晓文,毛亚丽. 血清STAT5B、NKAIN1 mRNA检测在乳腺癌中的应用价值[J]. 山东大学学报 (医学版), 2025, 63(7): 68-74.
[3] 王磊,常霄,王梓萌,李娇娇,崔书君,杨飞,朱月香. 瘤内及瘤周DCE-MRI影像组学对宫颈癌患者无进展生存期的预测价值[J]. 山东大学学报 (医学版), 2025, 63(6): 45-54.
[4] 贾若曦,吕丽,刘涵云,吴寅平,李凤彩,赵泽华,王凯,范玉琛. 血细胞计数相关标志物对慢加急性乙型肝炎肝衰竭患者28天预后的诊断价值[J]. 山东大学学报 (医学版), 2025, 63(6): 89-99.
[5] 杜雪,李春霞,刘云霞,张涛. 基于MFPC-Cox的结直肠癌患者预后动态预测模型[J]. 山东大学学报 (医学版), 2025, 63(5): 101-110.
[6] 杨卫芳,徐宏,刘元涛,赵蕙琛. 促甲状腺激素受体抗体在Graves病复发中的作用机制及其临床意义[J]. 山东大学学报 (医学版), 2025, 63(4): 116-121.
[7] 刘文钊,张远,马湘萍,魏峰涛,卜培莉. 内皮活化和应激指数预测值与心力衰竭患者死亡风险的关联[J]. 山东大学学报 (医学版), 2025, 63(11): 27-35.
[8] 陈文亮,王欢欢,郝金锦,弓蕊,赵强,张飞,高磊,董静逊. lncRNA PVT1表达在胃癌预后评估及恶性进展中的作用:基于列线图模型与细胞功能实验的研究[J]. 山东大学学报 (医学版), 2025, 63(10): 61-71.
[9] 郭姝画,樊扬,田风,王传新,杜鲁涛,李培龙,郭兴,徐硕. 微原纤维相关蛋白3在调控胶质瘤干细胞间充质表型转化中的作用[J]. 山东大学学报 (医学版), 2024, 62(6): 9-16.
[10] 魏闫若雪,李梓绮,刘春铖,刘晓晗,赵然,刘玉昆. 结直肠癌中SP1的瘤内异质性表达及其临床意义[J]. 山东大学学报 (医学版), 2024, 62(5): 89-94.
[11] 刘春铖,刘晓晗,魏闫若雪,李梓绮,刘玉昆,赵然. 结直肠癌中含溴结构域蛋白9的亚细胞定位模式及其临床意义[J]. 山东大学学报 (医学版), 2024, 62(4): 24-30.
[12] 杨雪彦,吴寅平,吕丽,赵泽华,马行宇,李凤彩,王凯,范玉琛. 单核细胞与淋巴细胞比值动态变化对慢加急性乙型肝炎肝衰竭预后的诊断价值[J]. 山东大学学报 (医学版), 2024, 62(3): 61-69.
[13] 刁玉洁,林琳,李文瑄,王洲洋,江蓓,胡迎迎,刘广义. NPR预测ANCA相关血管炎不良肾脏预后及其协同多因素优化模型[J]. 山东大学学报 (医学版), 2024, 62(2): 60-68.
[14] 景凯,徐志伟,李乐平. 基于GEO数据库探究结直肠肿瘤相关基因及其功能[J]. 山东大学学报 (医学版), 2024, 62(1): 21-30.
[15] 宋兆录,董正璇,彭传真,黄彩娜,胡克清,黄永胜,阎磊. 肾透明细胞癌中预后相关RNA编辑位点的筛选[J]. 山东大学学报 (医学版), 2023, 61(9): 69-78.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!